Found: 12
Select item for more details and to access through your institution.
Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 3, p. 443, doi. 10.1007/s00280-024-04682-4
- By:
- Publication type:
- Article
Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 16, p. 6853, doi. 10.1002/cam4.2558
- By:
- Publication type:
- Article
FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Failure of Initial Curative Treatment for Non-Metastatic Anal Squamous Cell Carcinoma: From Prognostic Factors Analysis to Stratified Treatment.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Radiosensitivity of Colon and Rectal Lung Oligometastasis Treated With Stereotactic Ablative Radiotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 11, p. 3177, doi. 10.1002/ijc.33146
- By:
- Publication type:
- Article
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 2, p. 375, doi. 10.1007/s10120-023-01455-5
- By:
- Publication type:
- Article
Cancer du rectum, le grand bouleversement ! Retour sur le congrès de l'ASCO 2020.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Effectiveness and Tolerability of Maintenance Capecitabine Administrated to Patients with Metastatic Pancreatic Cancer Treated with First-Line FOLFIRINOX.
- Published in:
- Oncology, 2016, v. 90, n. 5, p. 261, doi. 10.1159/000444854
- By:
- Publication type:
- Article
Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.918499
- By:
- Publication type:
- Article
Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal.
- Published in:
- Journal of Contemporary Brachytherapy, 2018, v. 10, n. 6, p. 522, doi. 10.5114/jcb.2018.81025
- By:
- Publication type:
- Article
A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2010, v. 105, n. 12, p. 2617, doi. 10.1038/ajg.2010.345
- By:
- Publication type:
- Article